Ancora Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $220K | Sell |
3,187
-50
| -2% | -$3.45K | ﹤0.01% | 689 |
|
2025
Q1 | $225K | Buy |
3,237
+425
| +15% | +$29.5K | 0.01% | 680 |
|
2024
Q4 | $242K | Buy |
2,812
+319
| +13% | +$27.4K | 0.01% | 662 |
|
2024
Q3 | $297K | Buy |
2,493
+325
| +15% | +$38.7K | 0.01% | 602 |
|
2024
Q2 | $309K | Buy |
2,168
+65
| +3% | +$9.28K | 0.01% | 574 |
|
2024
Q1 | $270K | Buy |
2,103
+181
| +9% | +$23.2K | 0.01% | 601 |
|
2023
Q4 | $199K | Sell |
1,922
-616
| -24% | -$63.7K | ﹤0.01% | 646 |
|
2023
Q3 | $231K | Hold |
2,538
| – | – | 0.01% | 613 |
|
2023
Q2 | $205K | Hold |
2,538
| – | – | 0.01% | 626 |
|
2023
Q1 | $202K | Buy |
2,538
+66
| +3% | +$5.25K | 0.01% | 625 |
|
2022
Q4 | $167K | Hold |
2,472
| – | – | ﹤0.01% | 688 |
|
2022
Q3 | $123K | Buy |
2,472
+100
| +4% | +$4.98K | ﹤0.01% | 813 |
|
2022
Q2 | $132K | Sell |
2,372
-164
| -6% | -$9.13K | ﹤0.01% | 849 |
|
2022
Q1 | $141K | Hold |
2,536
| – | – | ﹤0.01% | 898 |
|
2021
Q4 | $142K | Hold |
2,536
| – | – | ﹤0.01% | 909 |
|
2021
Q3 | $122K | Hold |
2,536
| – | – | ﹤0.01% | 900 |
|
2021
Q2 | $106K | Sell |
2,536
-888
| -26% | -$37.1K | ﹤0.01% | 878 |
|
2021
Q1 | $115K | Buy |
3,424
+1,524
| +80% | +$51.2K | ﹤0.01% | 824 |
|
2020
Q4 | $66K | Sell |
1,900
-1,528
| -45% | -$53.1K | ﹤0.01% | 808 |
|
2020
Q3 | $119K | Buy |
3,428
+464
| +16% | +$16.1K | ﹤0.01% | 672 |
|
2020
Q2 | $97K | Sell |
2,964
-60
| -2% | -$1.96K | ﹤0.01% | 700 |
|
2020
Q1 | $91K | Hold |
3,024
| – | – | ﹤0.01% | 768 |
|
2019
Q4 | $88K | Buy |
+3,024
| New | +$88K | ﹤0.01% | 788 |
|
2018
Q4 | – | Sell |
-4,024
| Closed | -$95K | – | 1008 |
|
2018
Q3 | $95K | Buy |
+4,024
| New | +$95K | ﹤0.01% | 764 |
|
2017
Q1 | – | Sell |
-9,500
| Closed | -$170K | – | 939 |
|
2016
Q4 | $170K | Buy |
+9,500
| New | +$170K | 0.01% | 578 |
|